Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,913 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of Fixed-dose Combinations of Amlodipine/Losartan Potassium/Chlorthalidone and Amlodipine/Losartan Potassium in Patients With Stage 2 Hypertension Inadequately Controlled With Amlodipine/Losartan Potassium: A Randomized, Double-blind, Multicenter, Phase III Study.
Hong SJ, Jeong HS, Han SH, Chang KY, Hong BK, Lee BK, Chae SC, Kim WS, Park CG, Heo JH, Lee SU, Kim YD, Kim KS, Choi JH, Kang HJ, Kim JJ, Kang SM, Choi YJ, Shin JH, Chun KJ, Shin DG, Park SH, Kwan J, Choi YJ, Jeong MH, Chae JK, Kim DW, Cho JR, Han KR, Won KH, Park SH, Lee SK, Kim SH, Jung J, Kim CH. Hong SJ, et al. Among authors: kim jj, kim dw, kim sh, kim ch, kim ks, kim yd, kim ws. Clin Ther. 2017 Oct;39(10):2049-2060. doi: 10.1016/j.clinthera.2017.08.013. Epub 2017 Sep 19. Clin Ther. 2017. PMID: 28939406 Free article. Clinical Trial.
Comparative efficacy and safety profile of amlodipine 5 mg/losartan 50 mg fixed-dose combination and amlodipine 10 mg monotherapy in hypertensive patients who respond poorly to amlodipine 5 mg monotherapy: an 8-week, multicenter, randomized, double-blind phase III noninferiority study.
Kang SM, Youn JC, Chae SC, Park CG, Yang JY, Kim MH, Hong TJ, Kim CH, Kim JJ, Shin DG, Jeong JW, Yoon JH, Park SH, Kwon J, Cho SY. Kang SM, et al. Among authors: kim jj, kim ch, kim mh. Clin Ther. 2011 Dec;33(12):1953-63. doi: 10.1016/j.clinthera.2011.11.007. Epub 2011 Dec 2. Clin Ther. 2011. PMID: 22136978 Clinical Trial.
Evaluation of the dose-response relationship of amlodipine and losartan combination in patients with essential hypertension: an 8-week, randomized, double-blind, factorial, phase II, multicenter study.
Park CG, Youn HJ, Chae SC, Yang JY, Kim MH, Hong TJ, Kim CH, Kim JJ, Hong BK, Jeong JW, Park SH, Kwan J, Choi YJ, Cho SY. Park CG, et al. Among authors: kim jj, kim ch, kim mh. Am J Cardiovasc Drugs. 2012 Feb 1;12(1):35-47. doi: 10.2165/11597170-000000000-00000. Am J Cardiovasc Drugs. 2012. PMID: 22217192 Clinical Trial.
Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapy.
Rhee MY, Baek SH, Kim W, Park CG, Park SW, Oh BH, Kim SH, Kim JJ, Shin JH, Yoo BS, Rim SJ, Ha JW, Doh JH, Ahn Y, Chae JK, Park JB, Kim SK, Kim CH. Rhee MY, et al. Among authors: kim jj, kim w, kim sh, kim ch, kim sk. Drug Des Devel Ther. 2015 Jun 2;9:2847-54. doi: 10.2147/DDDT.S82098. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26082615 Free PMC article. Clinical Trial.
A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan Monotherapy.
Kim KI, Shin MS, Ihm SH, Youn HJ, Sung KC, Chae SC, Nam CW, Seo HS, Park SM, Rhee MY, Kim MH, Cha KS, Kim YJ, Kim JJ, Chun KJ, Yoo BS, Park S, Shin ES, Kim DS, Il Kim D, Kim KH, Joo SJ, Jeong JO, Shin J, Kim CH. Kim KI, et al. Among authors: kim ds, kim jj, kim yj, kim ch, kim mh, kim kh. Clin Ther. 2016 Oct;38(10):2159-2170. doi: 10.1016/j.clinthera.2016.07.008. Epub 2016 Aug 5. Clin Ther. 2016. PMID: 27502326 Clinical Trial.
Comparison of the Efficacy and Safety of Fixed-dose S-Amlodipine/Telmisartan and Telmisartan in Hypertensive Patients Inadequately Controlled with Telmisartan: A Randomized, Double-blind, Multicenter Study.
Park CG, Ahn TH, Cho EJ, Kim W, Kim HS, Yang JY, Ryu JG, Kim CH, Hyeon MS, Tak SJ, Im SJ, Ha JW, Pyeon WB, Jae JG, Han GR, Doh JH, Im SW, Lee MM. Park CG, et al. Among authors: kim w, kim ch, kim hs. Clin Ther. 2016 Oct;38(10):2185-2194. doi: 10.1016/j.clinthera.2016.09.006. Epub 2016 Oct 6. Clin Ther. 2016. PMID: 27720505 Clinical Trial.
A Prospective Randomized, Double-Blind, Multi-Center, Phase III Clinical Trial Evaluating the Efficacy and Safety of Olmesartan/Amlodipine plus Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Dyslipidemia: A LEISURE Study.
Jo SH, Kang SM, Yoo BS, Lee YS, Youn HJ, Min K, Yu JM, Yoon HJ, Kim WS, Kim GH, Park JH, Kim SY, Kim CH. Jo SH, et al. Among authors: kim gh, kim ch, kim sy, kim ws. J Clin Med. 2022 Jan 11;11(2):350. doi: 10.3390/jcm11020350. J Clin Med. 2022. PMID: 35054044 Free PMC article.
Characteristics According to Frailty Status Among Older Korean Patients With Hypertension.
Choi JY, Lee HY, Lee JH, Hong Y, Park SK, Ryu DR, Lee JH, Hwang S, Kim KH, Lee SH, Kim SY, Park JH, Kim SH, Kim HL, Choi JH, Kim CH, Cho MC, Kim KI. Choi JY, et al. Among authors: kim hl, kim sh, kim ch, kim sy, kim kh, kim ki. J Korean Med Sci. 2024 Mar 18;39(10):e84. doi: 10.3346/jkms.2024.39.e84. J Korean Med Sci. 2024. PMID: 38501181 Free PMC article. Clinical Trial.
5,913 results